| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2003 | US6552013 For therapy of Alzheimer's disease |
| 04/22/2003 | US6552005 Treating with the adenovirus encoding cytosine deaminase gene and uracil phosphoribosyltranserase gene; administering 5-fluorocytosine; therapy with radiation |
| 04/22/2003 | US6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF |
| 04/22/2003 | US6551999 Angiogenesis inhibitor |
| 04/22/2003 | US6551998 Therapy and prophylaxis of bacterial infection in a mammal by administering peptide antibiotic compound |
| 04/22/2003 | US6551996 Super-active porcine growth hormone releasing hormone analog |
| 04/22/2003 | US6551995 For allogenic or xenogenic implants and which act as a carrier of the osteogenic protein to induce new bone formation in mammals |
| 04/22/2003 | US6551994 For inhibiting cellular adhesion |
| 04/22/2003 | US6551993 Administering partial glycine agonist to the glycine modulatory site of the NMDA receptor complex of mammals for therapy of cognitive dysfunction such as inattention |
| 04/22/2003 | US6551992 Stable insulin formulations |
| 04/22/2003 | US6551991 Recombinant proteins derived from HGF and MSP |
| 04/22/2003 | US6551990 Methods of inhibiting ectopic calcification |
| 04/22/2003 | US6551838 Microfabricated devices for the storage and selective exposure of chemicals and devices |
| 04/22/2003 | US6551830 Rh blood group antigen compositions and methods of use |
| 04/22/2003 | US6551826 Antisense modulation of raidd expression |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551821 Brain cyclic nucleotide gated ion channel and uses thereof |
| 04/22/2003 | US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 04/22/2003 | US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 04/22/2003 | US6551785 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility |
| 04/22/2003 | US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 04/22/2003 | US6551774 Determining the presence or amount of telomerase within a sample obtained from said patient, and correlating the amount of telomerase with a condition associated with an elevated level of telomerase activity |
| 04/22/2003 | US6551629 Cardiovascular promotion and maintenance composition |
| 04/22/2003 | US6551623 Immunomodulating compositions from bile |
| 04/22/2003 | US6551622 Storage-stable hydrophilic therapeutic agent is prepared by formulating therapeutic proteins with hydrophobically-derivatised carbohydrates; drug delivery |
| 04/22/2003 | US6551619 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
| 04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
| 04/22/2003 | US6551617 Taste masking coating composition |
| 04/22/2003 | US6551613 Dosage form comprising therapeutic formulation |
| 04/22/2003 | US6551607 Method for sequestration of skin irritants with substrate compositions |
| 04/22/2003 | US6551595 Smallpox inhibitor of complement enzymes (SPICE) protein and methods of inhibiting complement activation |
| 04/22/2003 | US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 04/22/2003 | US6551593 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| 04/22/2003 | US6551592 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 04/22/2003 | US6551590 Preferred hyaluronidase enzyme is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,OOO MW |
| 04/22/2003 | US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy |
| 04/22/2003 | US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 04/22/2003 | US6551585 Use of tumor necrosis factor as an adjuvant |
| 04/22/2003 | US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 04/22/2003 | CA2308780C Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | CA2235243C Method and preparations for stabilizing biological materials by drying methods without freezing |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |
| 04/22/2003 | CA2137793C Crystallization of m-csf |
| 04/22/2003 | CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 04/22/2003 | CA2101075C Peptides for the treatment of conditions caused by herpes virus infections |
| 04/22/2003 | CA2098295C G protein-coupled glutamate receptors |
| 04/22/2003 | CA2076386C Identification and expression of insect steroid receptor dna sequence |
| 04/22/2003 | CA2068630C Use of protein c or activated protein c |
| 04/22/2003 | CA1341427C Variants of immunoglobulin gene superfamily member |
| 04/18/2003 | CA2404050A1 Mb-1 analogs and uses thereof |
| 04/17/2003 | WO2003031942A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031651A2 Method of determining susceptibility to inflammatory bowel disease |
| 04/17/2003 | WO2003031650A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 04/17/2003 | WO2003031645A1 Preincubation assay method using single-stranded nucleic acid oligomer |
| 04/17/2003 | WO2003031643A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 04/17/2003 | WO2003031621A2 A human g protein coupled receptor |
| 04/17/2003 | WO2003031614A1 Low molecular weight gtpase rhot |
| 04/17/2003 | WO2003031606A2 Crystal structure of an aurora kinase catalytic domain, and use thereof |
| 04/17/2003 | WO2003031605A2 Human gtpase involved in chronic obstructive pulmonary disease (copd) |
| 04/17/2003 | WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 04/17/2003 | WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031594A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031587A2 Use of stat-6 inhibitors as therapeutic agents |
| 04/17/2003 | WO2003031584A2 Axon repair |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031576A2 Antisense modulation of inhibitor-kappa b kinase-gamma expression |
| 04/17/2003 | WO2003031575A2 A hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 04/17/2003 | WO2003031574A2 Elastase inhibitors |
| 04/17/2003 | WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | WO2003031474A2 Cd137 as a proliferation factor for hematopoietic stem cells |
| 04/17/2003 | WO2003031473A1 Leukocyte inactivation module |
| 04/17/2003 | WO2003031472A2 Insulin mimetic amino acid sequences |
| 04/17/2003 | WO2003031467A2 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031461A2 N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003031449A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003030946A1 Regulation of insulin production |
| 04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030936A1 Remedies for life style-related diseases or cibophobia and method of screening the same |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |
| 04/17/2003 | WO2003030929A1 Combination therapies using methyl donors or methyl donor enhancers and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 04/17/2003 | WO2003030928A2 Antitumor preparation |
| 04/17/2003 | WO2003030927A2 Use of thymulin-like peptides for making pain-relieving medicines |
| 04/17/2003 | WO2003030926A1 Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom |
| 04/17/2003 | WO2003030925A1 Angiogenesis drugs |
| 04/17/2003 | WO2003030924A1 Identification of specific modulators of bone formation |
| 04/17/2003 | WO2003030923A1 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |